Oxychem Pharmaceuticals Private Limited
About Oxychem Pharmaceuticals Private Limited
Data last updated:
Oxychem Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 19 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2018PTC336759. Its GSTIN is 10AACCO7488D1ZL (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gauri Kumari and Ranjit Kamat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 239 2nd Floor I.P Extn. West Vinod Nagar, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.99 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹14,384 (net margin 0.6%) and EBITDA of ₹15,718 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 53% over three years and 85% over five years.
Company details
Contact details
Oxychem Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressB – 239 2nd Floor I.P Extn. West Vinod Nagar, Delhi, India – 110092
- IndustryHealthcare, Manufacturing, Medical Appliances And Instruments
To see the full contact details of Oxychem Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oxychem Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Oxychem Pharmaceuticals Private Limited, buy the company report.
Financials of Oxychem Pharmaceuticals Private Limited
FY 2025 filings availableOxychem Pharmaceuticals Private Limited reported revenue of ₹23.99 Lakh (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 85% over five years, including 29% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15,718 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14,384 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oxychem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Oxychem Pharmaceuticals Private Limited
Oxychem Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gauri Kumari | Director | 19 Jul 2018 | 8 Years 3 Months | Current |
| Ranjit Kamat | Director | 19 Jul 2018 | 8 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Oxychem Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oxychem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oxychem Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCO7488D1ZL | Bihar | Active | 30 Nov 2019 |
To see the full GST registrations and return filing status of Oxychem Pharmaceuticals Private Limited, buy the company report.
Recent activity
Oxychem Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Gauri Kumari was appointed as Director on 19 Jul 2018.
Frequently asked questions
Oxychem Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 19 July 2018 (8+ years old) and is registered under CIN U33100DL2018PTC336759.
Oxychem Pharmaceuticals has 2 current directors:
- Gauri Kumari - Director
- Ranjit Kamat - Director
The latest financial statements of Oxychem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Oxychem Pharmaceuticals is 10AACCO7488D1ZL, registered in Bihar.
The CIN (Corporate Identification Number) of Oxychem Pharmaceuticals is U33100DL2018PTC336759. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oxychem Pharmaceuticals was incorporated on 19 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Gauri Kumari was appointed as Director on 19 Jul 2018. Ranjit Kamat was appointed as Director on 19 Jul 2018.
The registered office of Oxychem Pharmaceuticals is at B – 239 2nd Floor I.P Extn. West Vinod Nagar, Delhi, India – 110092.
Oxychem Pharmaceuticals operates in the healthcare industry, in the manufacturing segment.
Oxychem Pharmaceuticals can be reached at its registered office: B – 239 2nd Floor I.P Extn. West Vinod Nagar, Delhi, India – 110092.